George Cire, Chris James, and Paula Greenham review the major treatment modalities, the general indications for implant use and referral, and present a picture of current clinical practice as reflected in Cochlear Ltd’s Implant Recipient Observational Study (IROS).
Published in “Ear and Hearing” the paper presents a new method for the prediction of speech perception for individual recipients, providing a methodology that could make patient trials more efficient, potentially leading to implants that are personalized to an individual’s listening capability.
NYU Langone clinicians combined local anesthesia and conscious sedation (LA-CS) in cochlear implantation for the first time in 2006. The team has regularly performed the procedure ever since, establishing a mounting body of evidence of the approach’s efficacy and safety.
The research and support in practice by trained hearing health professionals provided the foundation to approve the indication be lowered to 9 months, along with the considerable developments in technology and evolving speech coding strategies in modern day cochlear implant devices.
Read More
The article estimates that Cochlear’s costs, including legal fees and interest, could exceed $750 million.
Read More
According to the article, pediatric surgeries to correct hearing problems have already resumed in China, mostly in the areas outside Hubei province, where the coronavirus was most prevalent.
Read More
MED-EL USA announced that Kenzi Cayton, 8, from Vancouver, Wash, was named the US winner of the...
Read More
There is a need to improve awareness and to better understand the impact and struggles of people who have unilateral hearing loss (UHL), the professionals who treat them, and those who work, live, and socialize with them. With better awareness comes better understanding, so health professionals can refer them rather than dismiss them. Moreover, better understanding can fuel motivation and allow the person with UHL to be more proactive about managing the condition while reducing anxiety.
Read More
Otolaryngologist Yi-Chun Carol Liu, MD, performed the surgery on an 18-year old, and the device was successfully activated on November 13, 2018.
Read More
What the hearing care field formerly knew as Sonitus Medical’s Soundbite system, a bone-conduction hearing device that resembled a dental bridge, has now re-emerged as Sonitus Technologies and a high-tech communications device called the ‘Molar Mic’ for military and rescue applications.
Read More
MED-EL USA, Durham, NC, has been granted FDA de novo clearance for the BONEBRIDGE™ bone conduction hearing implant system for individuals 12 years and older who have been diagnosed with conductive hearing loss, mixed hearing loss, or single-sided deafness.
Read More
There has been great interest in using speech-evoked cortical auditory evoked potentials (CAEP) as an objective hearing aid validation measure, because CAEPs allow us to assess the audibility of speech sounds at the highest (cortical) levels. Here is a review by Sridhar Krishnamurti and Larry Wise, as well as results from a study they conducted that suggests there is clinical value of CAEPs for assessing cortical changes from amplification, as well as using this data in audiology services to demonstrate patient benefit.
Read More
The Baha SoundArc was designed to provide children with conductive hearing loss, mixed hearing loss, or single-sided sensorineural deafness (SSD) with the hearing performance and amplification they need to facilitate language development on par with their hearing peers.
Read More
The technique has the potential to improve a surgical procedure that often fails because of incorrectly sized prosthetic implants, researchers said.
Read More
Can a fish with a malformed jaw tell us something about hearing loss in mice and humans? The answer is yes, according to a new publication in ‘Scientific Reports.’
Read More
MED-EL USA announced a search for future inventions through a global children’s competition, Ideas 4 Ears.
Read More
Clinically we all need to walk the fine line between the “values” of our clientele and the “facts” that we need to impart upon them as professionals. Marshall Chasin discusses this in relation to his own patients, as well as the OTC hearing aid debate.
Read More
Improved accuracy in reporting the hearing aid adoption rate, promoting hearing aid features using evidencebased data in language that the layman can understand, and unbundling prices are three things that our industry needs to improve upon.
Read More